Literature DB >> 22271486

Association of family history with cancer recurrence and survival in patients with gastric cancer.

Mi Ah Han1, Myueng Guen Oh, Il Ju Choi, Sook Ryun Park, Keun Won Ryu, Byung-Ho Nam, Soo-Jeong Cho, Chan Gyoo Kim, Jun Ho Lee, Young-Woo Kim.   

Abstract

PURPOSE: Family history of gastric cancer is a major risk factor for the disease. In this study, we investigated the prognoses of patients with gastric cancer with a family history. PATIENTS AND METHODS: We retrospectively reviewed data from 1,273 patients with gastric adenocarcinoma who had undergone gastrectomy between 2001 and 2005 at a tertiary cancer center hospital. A positive family history was defined as a self-reported history of cancer in first- or second-degree relatives. Patients were followed up until December 2009 for death or recurrence. Clinicopathologic characteristics were compared by family history. Kaplan-Meier plots and Cox proportional hazards regressions were applied for disease-free survival (DFS), recurrence-free survival (RFS), and overall survival (OS).
RESULTS: Of 1,273 patients, 263 patients (20.6%) had first-degree relatives with a history of gastric cancer. First-degree family history of gastric cancer was associated with better DFS, RFS, and OS (P = .012, .006, and .005, respectively). In patients with stage I or II gastric cancer, first-degree family history was not associated with survival. However, it was associated with a reduced risk of recurrence or mortality in patients with stage III or IV gastric cancer. Compared with patients without a family history, the adjusted hazard ratios for those with a first-degree family history of gastric cancer were 0.49 (95% CI, 0.29 to 0.84) for DFS, 0.51 (95% CI, 0.30 to 0.87) for RFS, and 0.47 (95% CI, 0.26 to 0.84) for OS in patients with stage III or IV gastric cancer.
CONCLUSION: A first-degree family history of gastric cancer is associated with improved survival after curative-intent surgery in patients with stage III or IV gastric cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22271486     DOI: 10.1200/JCO.2011.35.3078

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  27 in total

1.  Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.

Authors:  Surendra Pal Chaudhary; Eunice L Kwak; Jeffrey W Clark; Theodore S Hong; Katie L Hwang; Jochen K Lennerz; Ryan B Corcoran; Rebecca S Heist; Andrea L Russo; Aparna Parikh; Darrell R Borger; Lawrence S Blaszkowsky; Jason E Faris; Janet E Murphy; Christopher G Azzoli; Eric J Roeland; Lipika Goyal; Jill Allen; John T Mullen; David P Ryan; A John Iafrate; Samuel J Klempner
Journal:  Oncologist       Date:  2020-09-12

2.  Hereditary diffuse gastric cancer in two families: A case report.

Authors:  Irene Feroce; Davide Serrano; Roberto Biffi; Bruno Andreoni; Viviana Galimberti; Angelica Sonzogni; Luca Bottiglieri; Edoardo Botteri; Cristina Trovato; Monica Marabelli; Guglielmina Nadia Ranzani; Bernardo Bonanni
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

3.  Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?

Authors:  Bar Chikman; Tima Davidson; Hasan Kais; Igor Jeroukhimov; Ari Leshno; Judith Sandbank; Ariel Halevy; Ron Lavy
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

4.  Germline mutations in hereditary diffuse gastric cancer.

Authors:  Hao Zhang; Mengmeng Feng; Yi Feng; Zhaode Bu; Ziyu Li; Shuqin Jia; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

5.  Individual having a parent with early-onset gastric cancer may need screening at younger age.

Authors:  Hee-Won Kwak; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Bang Wool Eom; Hong Man Yoon; Jungnam Joo; Keun Won Ryu; Young-Woo Kim
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

6.  Influence of different hypoxia models on metastatic potential of SGC-7901 gastric cancer cells.

Authors:  Zhi-Feng Miao; Ting-Ting Zhao; Zhen-Ning Wang; Ying-Ying Xu; Xiao-Yun Mao; Jian-Hua Wu; Xing-Yu Liu; Hao Xu; Yi You; Hui-Mian Xu
Journal:  Tumour Biol       Date:  2014-04-12

Review 7.  Current Perspectives on Gastric Cancer.

Authors:  Juan M Marqués-Lespier; María González-Pons; Marcia Cruz-Correa
Journal:  Gastroenterol Clin North Am       Date:  2016-09       Impact factor: 3.806

Review 8.  Hereditary diffuse gastric cancer: how to look for and how to manage it.

Authors:  Karol Polom; Daniele Marrelli; Alessia D'Ignazio; Franco Roviello
Journal:  Updates Surg       Date:  2018-06-04

9.  Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma.

Authors:  Zhen-Li Li; Jun Han; Kai Liu; Hao Xing; Han Wu; Wan Yee Lau; Timothy M Pawlik; Chao Li; Ming-Da Wang; Jiong-Jie Yu; Meng-Chao Wu; Feng Shen; Tian Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2019-04       Impact factor: 7.293

10.  Cancer Visibility among Iranian Familial Networks: To What Extent Can We Rely on Family History Reports?

Authors:  Hossein Molavi Vardanjani; Mohammad Reza Baneshi; AliAkbar Haghdoost
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.